| 000 | 01414nam a22004095i 4500 | ||
|---|---|---|---|
| 001 | 978-0-387-44961-6 | ||
| 003 | DE-He213 | ||
| 005 | 20130515020504.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2006 xxu| s |||| 0|eng d | ||
| 020 |
_a9780387449616 _9978-0-387-44961-6 |
||
| 024 | 7 |
_a10.1007/978-0-387-44961-6 _2doi |
|
| 050 | 4 | _aRM1-950 | |
| 072 | 7 |
_aMMG _2bicssc |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615 _223 |
| 100 | 1 | _aBorchardt, Ronald T. | |
| 245 | 1 | 0 |
_aOptimizing the “Drug-Like” Properties of Leads in Drug Discovery _h[electronic resource] / _cedited by Ronald T. Borchardt, Edward H. Kerns, Michael J. Hageman, Dhiren R. Thakker, James L. Stevens. |
| 260 |
_aNew York, NY : _bSpringer New York, _c2006. |
||
| 300 | _bdigital. | ||
| 490 | 0 |
_aBiotechnology: Pharmaceutical Aspects ; _vIV |
|
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aToxicology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 700 | 1 | _aKerns, Edward H. | |
| 700 | 1 | _aHageman, Michael J. | |
| 700 | 1 | _aThakker, Dhiren R. | |
| 700 | 1 | _aStevens, James L. | |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9780387340562 |
| 830 | 0 |
_aBiotechnology: Pharmaceutical Aspects ; _vIV |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-0-387-44961-6 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c67068 _d67068 |
||